Dr. Deininger received his MD from the University of Würzburg. He trained in Internal Medicine and Hematology/Oncology, followed a PhD in leukemia biology at Imperial College, London. In 2002 he was recruited to Oregon Health & Science University and in 2007 became Head of Hematologic Malignancies and Program Leader at Knight Cancer Institute. In 2010 he became Division Chief for Hematology and Hematologic Malignancies at the University of Utah, Senior Director for Transdisciplinary Research at Huntsman Cancer Institute, and M.M. Wintrobe Professor of Medicine. In 2021 he was appointed Chief Scientific Officer and Director of the Versiti Blood Research Institute, Milwaukee and Professor of Medicine at the Medical College of Wisconsin. Dr. Deininger’s research spans the entire spectrum of myeloid malignancies, including mastocytosis. As a physician-scientist has led an NIH-funded lab almost 20 years and served as PI on numerous clinical trials. He has published more than 300 peer-reviewed manuscripts.